Enclomiphene Citrate Cost in South Carolina 2026

What Is Enclomiphene Citrate and Why Does the Price Vary So Much?

Enclomiphene citrate is the trans-isomer of clomiphene, separated from the cis-isomer (zuclomiphene) that is responsible for many of the visual and estrogenic side effects associated with standard clomiphene citrate. By acting selectively as an estrogen-receptor antagonist at the hypothalamus and pituitary, enclomiphene raises gonadotropin-releasing hormone pulse frequency, which in turn lifts both LH and FSH output, stimulating endogenous testosterone production without suppressing spermatogenesis the way exogenous testosterone does. [1]

Price varies because the U.S. regulatory story is still unfinished. Repros Therapeutics pursued FDA approval under the brand name Androxal for secondary hypogonadism in men, and the compound demonstrated statistically significant testosterone restoration in Phase III trials. [2] The FDA has not yet granted final NDA approval for an oral enclomiphene product, so no single manufacturer controls a branded retail price in U.S. pharmacy chains. What South Carolina patients encounter instead is compounded enclomiphene from 503A pharmacies, where pricing reflects the pharmacy's ingredient and compounding costs rather than a manufacturer's list price.

That regulatory gap also explains the absence of a standard insurance reimbursement rate. Without an approved NDA, insurance formularies have no defined drug code to reimburse, and prior authorization requests are nearly always denied for hypogonadism. The result: most South Carolina men pay out of pocket. [3]

Current Enclomiphene Citrate Cash Price in South Carolina (2026)

The going rate at South Carolina 503A compounding pharmacies in 2026 is approximately $90 per month for a standard supply of enclomiphene citrate oral capsules at doses between 12.5 mg and 25 mg once daily.

That $90 figure covers a 30-day supply at a typical therapeutic dose. It is not a copay. It is the full cash price the patient pays at the pharmacy window or through an online compounding pharmacy that ships to SC addresses. Some pharmacies price single-isomer enclomiphene slightly higher than racemic clomiphene because the purification step adds manufacturing cost. A small number of telehealth platforms bundle the medication cost into a monthly membership fee of $120 to $180, which includes the prescriber visit, lab review, and the compound itself. When comparing quotes, ask whether the fee covers labs or only the drug. Labs for testosterone, LH, and FSH add roughly $60 to $120 if drawn through a cash-pay lab in South Carolina. [4]

Contrast this with racemic clomiphene citrate 25 mg tablets, which are FDA-approved for female infertility and can be purchased at South Carolina retail pharmacies for under $30 per month via GoodRx-type discount programs. Prescribers sometimes offer clomiphene off-label as a lower-cost alternative for male hypogonadism, though the zuclomiphene component accumulates over weeks and may cause more side effects. [5]

HealthRX South Carolina Enclomiphene Cost Comparison Framework (2026)

| Source | Typical Monthly Cost | Includes Telehealth Visit? | Requires In-Person Visit? | |---|---|---|---| | SC 503A compounding pharmacy (direct) | ~$90 | No | Depends on prescriber | | Telehealth platform bundled plan | $120-$180 | Yes | No | | SC retail chain pharmacy (branded, if approved) | Not yet available | No | No | | SC Medicaid | Not covered | N/A | N/A | | Off-label clomiphene (racemic) as alternative | $25-$40 | No | Depends on prescriber |

Is Enclomiphene Citrate Covered by South Carolina Medicaid?

South Carolina Medicaid does not cover enclomiphene citrate for secondary hypogonadism. The indication is off-label because no FDA-approved NDA exists for this specific use in men, and Medicaid programs across the country are not obligated to cover compounds for unapproved indications. [6]

The South Carolina Department of Health and Human Services administers Medicaid under a managed care model through carriers including Absolute Total Care, Healthy Blue, Molina Healthcare of South Carolina, and Select Health of South Carolina. None of these four plans list enclomiphene citrate on their 2026 preferred drug lists. An appeal based on medical necessity is possible in theory, but approvals are rare. A prescriber would need to document failed or contraindicated alternatives, a confirmed low total testosterone on two morning fasting samples, and a clinical reason why exogenous testosterone replacement is not appropriate (such as active fertility plans). Even with that documentation, denial is the most likely outcome. [7]

Men enrolled in SC Medicaid who need treatment for secondary hypogonadism should discuss injectable testosterone cypionate or testosterone enanthate with their provider. Both are FDA-approved for hypogonadism, and testosterone cypionate 200 mg/mL vials appear on multiple SC Medicaid formularies at a low or no-cost tier. [8]

Is Compounded Enclomiphene Citrate Legal in South Carolina?

Compounded enclomiphene citrate is legal in South Carolina when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. [9]

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that produce drug preparations for individual patients. In South Carolina, the Board of Pharmacy licenses and inspects compounding pharmacies, and facilities must comply with USP Chapter 795 standards for non-sterile preparations. An oral capsule or tablet containing enclomiphene citrate is a non-sterile preparation and falls within normal 503A scope. [10]

One practical limitation: 503A pharmacies may not produce large batches for office stock or for speculative commercial sale. Each prescription must represent a specific patient with a legitimate clinical relationship with the prescribing provider. A telehealth provider who conducts a proper intake evaluation, reviews lab results, and issues an individualized prescription satisfies that requirement under South Carolina law.

503B outsourcing facilities, which produce sterile injectables in bulk, are not relevant here because enclomiphene is oral. Patients should verify that the compounding pharmacy they use holds a current South Carolina pharmacy license, which can be confirmed through the SC Board of Pharmacy license verification portal. [11]

South Carolina Telehealth Access for Enclomiphene Citrate

Telehealth prescribing of enclomiphene citrate is permitted in South Carolina, and it is the most common route through which men obtain this medication in the state.

South Carolina follows the Interstate Medical Licensure Compact, and the state's telemedicine laws allow synchronous audio-video visits to establish a valid patient-provider relationship. A prescriber licensed in South Carolina may issue a controlled substance or non-controlled prescription after conducting a real-time video consultation and reviewing relevant clinical data including labs. Enclomiphene citrate is not a controlled substance, so prescribing via telehealth faces fewer restrictions than, say, testosterone injectables. [12]

The typical telehealth workflow for enclomiphene in South Carolina:

1. Patient completes an online intake form covering symptoms, medical history, and current medications.
2. A synchronous video visit with a licensed prescriber (usually an endocrinologist, urologist, or men's health physician) reviews morning total testosterone drawn on two separate days, plus LH, FSH, CBC, and a metabolic panel.
3. If testosterone is consistently below 300 ng/dL with inappropriately normal or low LH and FSH confirming secondary hypogonadism, the prescriber writes a prescription for compounded enclomiphene citrate. [13]
4. The prescription is transmitted electronically to a licensed South Carolina 503A pharmacy or a pharmacy licensed to ship to SC.
5. The patient receives a 30-day supply by mail.

Follow-up labs at 8 to 12 weeks typically include total testosterone, LH, FSH, and a hematocrit. Some providers also check estradiol because enclomiphene's anti-estrogenic mechanism can shift the testosterone-to-estrogen ratio. [14]

Clinical Evidence Supporting Enclomiphene Use in Male Hypogonadism

The clinical rationale for choosing enclomiphene over exogenous testosterone centers on preserving the hypothalamic-pituitary-gonadal axis and maintaining fertility. Kim et al. (BJU International, 2016) conducted a systematic review and found that selective estrogen receptor modulators including clomiphene and its isomers raised serum testosterone to normal ranges in hypogonadal men while maintaining or improving sperm parameters, a benefit exogenous testosterone does not share. [1]

A Phase III randomized controlled trial of enclomiphene citrate 12.5 mg and 25 mg once daily versus transdermal testosterone gel 1.62% in men with secondary hypogonadism demonstrated that enclomiphene normalized testosterone (to 300-1000 ng/dL) in approximately 75% of men at 16 weeks. Sperm concentration declined by roughly 25% in the testosterone gel group versus less than 5% in the enclomiphene groups. [2] That difference is clinically meaningful for men who have not completed their families.

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism states: "We suggest that testosterone therapy not be offered to men who desire fertility in the near term." [15] Enclomiphene's mechanism directly addresses that contraindication by stimulating endogenous production rather than replacing it. The American Urological Association similarly notes in its 2022 male infertility guidelines that clomiphene citrate and related compounds are used as empirical therapy for idiopathic male factor infertility, acknowledging the off-label nature of the use. [16]

Mean testosterone levels in Phase III enclomiphene studies rose from a baseline around 230 ng/dL to roughly 420-460 ng/dL by week 8, with LH and FSH both increasing from baseline, confirming intact pituitary and testicular response. [2] The drug carries a half-life of approximately 10 hours for the enclomiphene isomer versus several weeks for zuclomiphene, which is why daily dosing produces a more stable hormonal profile than racemic clomiphene in men. [5]

How to Reduce Enclomiphene Citrate Costs in South Carolina

Several strategies can bring the monthly cost below the standard $90 benchmark.

Use a telehealth platform that bundles labs. Some direct-to-patient men's health platforms negotiate discounted lab rates with national draw sites such as LabCorp and Quest. A bundled plan that includes labs, the telehealth visit, and the compound at $150 per month may cost less overall than paying $90 for the compound plus $120 for unbundled labs plus a separate $75 physician visit fee. [4]

Ask about manufacturer or pharmacy savings programs. While no branded enclomiphene savings card exists for an FDA-approved product yet, several compounding pharmacies that serve South Carolina patients offer loyalty pricing for three-month or six-month prepaid supplies. Patients who pay for three months upfront may pay as little as $75 per month. [17]

Compare multiple South Carolina 503A pharmacies. Compounding prices are not regulated, and pharmacy-to-pharmacy variation of 20% to 30% is common for the same compound and dose. Calling two or three licensed SC compounding pharmacies for a quote is the simplest cost-reduction step.

Consider racemic clomiphene if fertility is not the primary concern. If the treating physician agrees that off-label racemic clomiphene citrate is medically appropriate, a 30-day supply costs under $30 at many SC retail pharmacies using discount programs. The side effect profile differs, but for some men the clinical result is similar at a fraction of the cost. [5]

Confirm HSA/FSA eligibility. Because enclomiphene is prescribed by a licensed physician for a diagnosed condition, out-of-pocket costs paid to a licensed pharmacy are generally eligible for reimbursement from a Health Savings Account or Flexible Spending Account under IRS Publication 502 rules. This does not reduce the sticker price but does reduce after-tax cost by 22% to 37% depending on the patient's marginal tax bracket. [18]

Insurance Coverage for Enclomiphene Citrate in South Carolina

Private insurance coverage for enclomiphene citrate in South Carolina is uncommon and inconsistent across carriers.

BlueCross BlueShield of South Carolina, Cigna, Aetna, and UnitedHealthcare all manage formularies that do not currently list an approved enclomiphene citrate product. Because the drug lacks FDA approval for male hypogonadism (the primary off-label use for which men seek it), insurers classify any prescription as off-label and compounded, both of which trigger automatic non-coverage under most plan documents. [3]

Prior authorization appeals have a low but non-zero success rate when the prescriber submits documentation showing: (a) confirmed secondary hypogonadism on two morning testosterone measurements below 300 ng/dL, (b) inappropriately low or low-normal LH and FSH ruling out primary hypogonadism, (c) an active fertility goal making exogenous testosterone contraindicated, and (d) documentation that the patient was counseled about off-label status. [15] Even with all four elements, approval is rare through SC private insurers.

Some patients covered by large self-insured employer plans administered by these carriers have reported success after their prescribers submitted formal appeals citing the Endocrine Society guideline language on preserving fertility. That success is not guaranteed and depends heavily on the specific plan document. [15]

Monitoring Costs to Factor Into Your Total SC Enclomiphene Budget

The drug itself is only part of the total cost. Men in South Carolina should budget for the following monitoring expenses over the first six months of enclomiphene therapy. [13]

Baseline labs (before starting):

• Total testosterone (two morning draws, separate days): $40-$80 each at cash-pay labs
• LH and FSH: $30-$60 combined
• CBC: $20-$40
• Comprehensive metabolic panel: $25-$45
• Estradiol (sensitive assay): $50-$80

Total baseline lab cost without insurance: approximately $185-$305 at South Carolina cash-pay draw sites.

Follow-up labs at 8-12 weeks:

• Total testosterone, LH, FSH, hematocrit: $80-$140 combined

Annualized, a patient managing enclomiphene therapy with quarterly monitoring pays roughly $400-$600 in labs per year on top of the $1,080 annual drug cost at $90 per month. Some telehealth platforms reduce that total by bundling discounted lab rates into their membership fee. [4] A prescriber licensed in South Carolina must review and sign off on those labs before continuing the prescription regardless of whether the visit is in-person or via video. [12]

What South Carolina Men Should Ask Before Starting Enclomiphene

Getting the diagnosis right before spending money on enclomiphene is not optional. Treating primary hypogonadism (Klinefelter syndrome, testicular failure, prior orchitis) with enclomiphene will fail because the testes cannot respond to elevated LH. The compound works only when the hypothalamic-pituitary axis is the dysfunction and the testes retain functional capacity. [1]

A morning total testosterone below 300 ng/dL on two separate draws, combined with LH and FSH that are normal or low rather than elevated, points to secondary hypogonadism and indicates a reasonable chance of enclomiphene response. [13] An LH above 10 IU/L with a low testosterone points toward primary hypogonadism, and enclomiphene is unlikely to help in that case.

Men should also confirm the prescriber is licensed in South Carolina and that the compounding pharmacy they use appears on the SC Board of Pharmacy licensee list. Short of those two checks, there is no guarantee that the prescription or the compound meets legal and quality standards for the state.